Brentuximab Vedotin with Adriamycin, Vinblastine and Dacarbazine for Patients Aged 18-59 Years with Untreated Advanced-stage Classical Hodgkin Lymphoma: a Real-life Experience
Clinical trial NCT06857500 · COMPLETED
Trial details
- NCT number
- NCT06857500
- Sponsor
- Federico II University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-01-01
- Primary completion
- 2025-01-30
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.